- Drug Pipelines
- July 2020
- 152 Pages
Global
From €1813EUR$2,000USD£1,569GBP
- Drug Pipelines
- July 2020
- 1191 Pages
Global
From €2266EUR$2,500USD£1,961GBP
- Drug Pipelines
- July 2020
- 222 Pages
Global
From €1813EUR$2,000USD£1,569GBP
- Drug Pipelines
- December 2019
- 32 Pages
Global
From €3173EUR$3,500USD£2,745GBP
- Report
- May 2024
- 75 Pages
Global
From €9061EUR$9,995USD£7,839GBP
- Report
- February 2024
- 226 Pages
Global
From €3626EUR$4,000USD£3,137GBP
- Report
- February 2024
- 79 Pages
Global
From €9061EUR$9,995USD£7,839GBP
- Report
- August 2022
- 95 Pages
Global
From €3626EUR$4,000USD£3,137GBP
- Report
- December 2021
- 124 Pages
Global
From €9968EUR$10,995USD£8,623GBP
- Newsletter
- August 2025
- 2 Pages
Global
From €119EUR$131USD£103GBP
- Report
- March 2025
- 201 Pages
China
From €3626EUR$4,000USD£3,137GBP
- Report
- August 2024
- 207 Pages
China
From €3626EUR$4,000USD£3,137GBP
- Report
- August 2024
- 238 Pages
China
From €3626EUR$4,000USD£3,137GBP
- Report
- June 2024
- 211 Pages
Global
From €4528EUR$4,995USD£3,917GBP
- Report
- June 2024
- 200 Pages
Global
From €4528EUR$4,995USD£3,917GBP
- Report
- June 2024
- 200 Pages
Global
From €7207EUR$7,950USD£6,235GBP
- Report
- May 2024
- 250 Pages
Global
From €4528EUR$4,995USD£3,917GBP
- Report
- May 2024
- 250 Pages
Global
From €4528EUR$4,995USD£3,917GBP
- Report
- May 2024
- 182 Pages
Global
From €4080EUR$4,500USD£3,529GBP
- Report
- March 2024
- 81 Pages
Global
€4528EUR$4,995USD£3,917GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more